Different strengths – different ISV? [Power / Sample Size]

posted by ElMaestro  – Denmark, 2014-12-21 21:42 (4208 d 12:41 ago) – Posting: # 14129
Views: 10,013

Hi again mittyri,

❝ For exapmle, the formulation 50mg is registered and we're going to conduct the study with the formulation 100 mg.

❝ The drug has linear PK to 120 mg according to the literature.

❝ Could we plan our study with ISV derived from the previous data? Is it safe enough?


A difficult topic. I am aware of people have a theoretical concern about ISV varying with strength but I don't remember ever having seen solid data quantifying the phenomenon.
I think I would just use the ISV from the previous study if that's available.

Pass or fail!
ElMaestro

Complete thread:

UA Flag
Activity
 Admin contact
23,656 posts in 4,994 threads, 1,570 registered users;
292 visitors (0 registered, 292 guests [including 14 identified bots]).
Forum time: 11:24 CEST (Europe/Vienna)

It requires a very unusual mind
to undertake the analysis of the obvious.    Alfred North Whitehead

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5